Medical Research News

RSS

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases.

6 May 2020

Veterans experience delayed homelessness long after discharge, shows study

According to a new study in the American Journal of Preventive Medicine, published by Elsevier, homelessness among US military veterans rarely occurs immediately after military discharge, but instead takes years to manifest with risk increasing over subsquent years.

6 May 2020

Study explores the impact of lockdown on older people with or without dementia

It has long been known that disrupted sleep can increase the risk of dementia and anecdotal evidence suggests COVID-19 anxiety is having a detrimental effect on sleep.

6 May 2020

People who spend time in the garden are more likely to report general good health

Spending time in the garden is linked to similar benefits for health and wellbeing as living in wealthy areas, according to a new large-scale study.

6 May 2020

Study: Financial incentive can dramatically increase physicians’ training in opioid treatment medication

A new study shows that a financial incentive can dramatically increase the number of emergency department physicians trained to prescribe a potentially life-saving medication that prevents patients from fatal opioid overdose.

6 May 2020

New method to trace COVID-19 in wastewater can be used to track future outbreaks

Ben-Gurion University of the Negev (BGU) scientists have developed a new methodology to trace the SARS-CoV-2 virus through the sewage and wastewater systems, which could potentially be used to track existing and future outbreaks of the coronavirus.

6 May 2020

Is ACEI, ARB use linked to testing positive for COVID-19?

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.

6 May 2020

Public perception of SARS-CoV-2 influences health behavior

A new study published in the Journal of Risk Research in April 2020 shows that public health behaviors aimed at preventing viral spread are influenced by public risk perception, which varies between countries around the world.

6 May 2020

Study shows thinking and walking speed usually decline together

Do thinking and walking go hand in hand in determining the health course of senior adults? A study published by UT Health San Antonio researchers found that, indeed, the two functions often parallel each other in determining a person's health trajectory.

6 May 2020

Study provides more insight into the initiation and progression of human cancers

Volume 11, Issue 18 of @Oncotarget Clinical implications of chromatin accessibility assessed by ATAC-seq profiling in human cancers especially in a large patient cohort is largely unknown.

6 May 2020

Study provides evidence for safety and efficacy of chloroquine in COVID-19

After a pilot study (Huang et al.Journal of Molecular Cell Biology, in press), having proved the safety and effectiveness of the drug to reduce the viral RNA to undetectable levels in 10 COVID-19 patients, the researchers began this current study, published on the preprint server medRxiv.

5 May 2020

Israeli scientists discover monoclonal antibody that neutralizes SARS-CoV-2

Now, in a significant medical breakthrough, Israel's Institute for Biological Research Institute (IIBRI) has wrapped up the development of a potential treatment for the coronavirus disease. The scientists say they have identified an antibody that neutralizes SARS-CoV-2.

5 May 2020

First French COVID-19 case was in December 19

The coronavirus disease (COVID-19), formerly known as the novel coronavirus infection, was first reported in late December 2019 in Wuhan City in China. Many health experts believe that the virus had spread way before it was identified as the culprit for many pneumonia-like diseases. Now, a French doctor says that the coronavirus reached France back in December when it admitted a pneumonia patient into hospital.

5 May 2020

How non-pharmaceutical interventions affect COVID lockdown relaxation

An American study published on the preprint server medRxiv in April 2020 shows the frightening limitations of any relaxation of social distancing norms with respect to containing the COVID-19 spread. Currently, the illness is the cause of massive numbers of deaths, close to 70,000, as well as widespread business shutdowns, loss of revenue and employment, and social disruptions in America.

5 May 2020

SARS-CoV-2 genome shows mutation hotspots and type-specific distribution

Now, a new study published on the preprint server bioRxiv reports on a large scale analysis of SARS-CoV-2 genomes and reveals a clonal geo-distribution and rich genetic variations.

5 May 2020

COVID-19 and exposure to air pollution

A scientist from the Netherlands has worked on a study that looked at the association between COVID-19 infections and exposure to air pollution. Researcher Bo Pieter Johannes Andrée’s study titled “Incidence of COVID-19 and Connections with Air Pollution Exposure Evidence from the Netherlands” was released prior to the peer review process on the online server Medrxiv.

5 May 2020

Shortages of PPE for healthcare workers could be tackled using social media and 3D printing

Researchers have come up with the use of social media and 3D printing techniques to deal with the severe shortage of personal protective equipment (PPEs) for healthcare workers who are dealing with the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The

5 May 2020

COVID-19 infection risk and outcomes explained by the cell receptor genetic variability

Genetic variants in the angiotensin‐converting enzyme 2 (ACE2) receptor, utilized by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) for cell entry, are predicted to either encourage or inhibit interaction with viral proteins and subsequently contribute to genetic risk in coronavirus disease (COVID-19). This is the key finding of a new study available on the preprint server bioRxiv*.

5 May 2020

Cat coronavirus drug shows promise for treatment of COVID-19

“They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals (cats),” writes the team. “The work here lays the framework for their use in human trials for the treatment of COVID-19.”

5 May 2020

Allergic reactions can occur without being triggered by an allergen, finds study

Allergic reactions can occur without being triggered by an allergen such as grass or birch pollen - it is enough for the patient to be back in the same place in which he or she was previously exposed to the allergen, as researchers at the University of Tübingen have found.

5 May 2020

Medical Research News

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

Veterans experience delayed homelessness long after discharge, shows study

Study explores the impact of lockdown on older people with or without dementia

People who spend time in the garden are more likely to report general good health

Study: Financial incentive can dramatically increase physicians’ training in opioid treatment medication

New method to trace COVID-19 in wastewater can be used to track future outbreaks

Is ACEI, ARB use linked to testing positive for COVID-19?

Public perception of SARS-CoV-2 influences health behavior

Study shows thinking and walking speed usually decline together

Study provides more insight into the initiation and progression of human cancers

Study provides evidence for safety and efficacy of chloroquine in COVID-19

Israeli scientists discover monoclonal antibody that neutralizes SARS-CoV-2

First French COVID-19 case was in December 19

How non-pharmaceutical interventions affect COVID lockdown relaxation

SARS-CoV-2 genome shows mutation hotspots and type-specific distribution

COVID-19 and exposure to air pollution

Shortages of PPE for healthcare workers could be tackled using social media and 3D printing

COVID-19 infection risk and outcomes explained by the cell receptor genetic variability

Cat coronavirus drug shows promise for treatment of COVID-19

Allergic reactions can occur without being triggered by an allergen, finds study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News